Indefinite Delivery Contract SPE2DR25D9756

The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) worth up to $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, under the SPE2DR program, covers the delivery of a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide.

The IDC was awarded as a single-award contract and does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories. The contract has an ultimate completion date of December 31, 2036 and provides the DLA the flexibility to issue firm fixed-price delivery orders for a wide variety of pharmaceutical items. This IDC is part of the DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple regional prime vendor contracts with an estimated total value of $30.3 billion to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, the U.S. Coast Guard, and the U.S. Naval Fleet.